Home/Filings/4/0001209191-17-067564
4//SEC Filing

RIGBY JONATHAN 4

Accession 0001209191-17-067564

CIK 0001619087other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 3:31 PM ET

Size

7.5 KB

Accession

0001209191-17-067564

Insider Transaction Report

Form 4
Period: 2017-12-28
RIGBY JONATHAN
DirectorSee Remarks
Transactions
  • Award

    Ordinary Shares

    2017-12-28+83,21083,210 total
  • Award

    Stock Option (right to buy)

    2017-12-28+163,394163,394 total
    Exercise: $3.65Exp: 2027-12-28Ordinary Shares (163,394 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of SteadyMed Ltd. ordinary shares.
  • [F2]The restricted stock units ("RSUs")are 50% time-based and 50% performance based grants. 50% of the RSUs shall vest on June 30, 2018 and 50% shall vest upon approval by the FDA of the New Drug Application for Trevyent.
  • [F3]1/3rd of the Option Shares shall vest on the first anniversary of the grant date. Thereafter, the remaining balance of the Option Shares shall vest in a series of 8 equal consecutive quarterly installments until fully vested.

Issuer

SteadyMed Ltd.

CIK 0001619087

Entity typeother

Related Parties

1
  • filerCIK 0001356227

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 3:31 PM ET
Size
7.5 KB